Alert: Medicare to limit coverage for Aduhelm, an Alzheimer's drug with questionable benefits that triggered a jump in premiums
Published
WASHINGTON (AP) — Medicare to limit coverage for Aduhelm, an Alzheimer's drug with questionable benefits that triggered a jump in premiums.
Full Article